(Q37151410)

English

Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease

scientific article published on June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Rejko Krüger

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

author name string

Carola Schiesling

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Nicole Kieper

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Kay Seidel

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Neuropathology and Applied Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

255-271

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

A comparison of clinical and pathological features of young- and old-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Synucleinopathies: clinical and pathological implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Clinical genetic analysis of Parkinson's disease in the Contursi kindred

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Neurobiology of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkinson's disease: one biochemical pathway to fit all genes?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Drosophila as a model for human neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Association between early-onset Parkinson's disease and mutations in the parkin gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

How much phenotypic variation can be attributed to parkin genotype?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Lewy bodies and parkinsonism in families with parkin mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

How does parkin ligate ubiquitin to Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin enhances mitochondrial biogenesis in proliferating cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Intron-exon structure of ubiquitin c-terminal hydrolase-L1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

UCHL1 is a Parkinson's disease susceptibility gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

PINK1 mutations are associated with sporadic early-onset parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

PINK1 protein in normal human brain and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

PINK1, a gene product of PARK6, accumulates in alpha-synucleinopathy brains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The role of pathogenic DJ-1 mutations in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Genetic clues to the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Mutations in DJ-1 are rare in familial Parkinson disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

DJ-1 has a role in antioxidative stress to prevent cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Impact of recent genetic findings in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Anatomical localization of leucine-rich repeat kinase 2 in mouse brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

LRRK2 expression linked to dopamine-innervated areas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

The identification of pats1, a novel gene locus required for cytokinesis in Dictyostelium discoideum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Localization of LRRK2 to membranous and vesicular structures in mammalian brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Kinase signaling pathways as potential targets in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Clinicopathological aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Parkin mutations and susceptibility alleles in late-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

PARK6-linked parkinsonism occurs in several European families.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

LRRK2 mutations are a common cause of Parkinson's disease in Spain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

A heterozygous effect for PINK1 mutations in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2008.00952.X

21 January 2018

Identifiers

10.1111/J.1365-2990.2008.00952.X

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37151410&oldid=1697813585"